Track DermTech's long-term debt ($50M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2024), DMTK shows a long-term debt of $50M. That compares with $54M in the prior-year period — down 6.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DMTK's long-term debt is now $50M (was $54M) — a 6.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether DermTech is outperforming or lagging.
Tracking DMTK's long-term debt over time shows whether DermTech is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $54M in the prior-year period — down 6.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has DermTech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $50M) with ownership activity and broader fundamentals.
DermTech's long-term debt is $50M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.